Skip to main content

ERRATUM article

Front. Neurol., 15 May 2023
Sec. Multiple Sclerosis and Neuroimmunology
Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1213956

Erratum: Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)

This article is an erratum on:

  1. Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)

    1. Read original article
\r\nFrontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)

by Kozik, V., Schwab, M., Thiel, S., Hellwig, K., Rakers, F., and Dreiling, M. (2022). Front. Neurol. 13:830057. doi: 10.3389/fneur.2022.830057

Due to a production error, the reference for “11” was incorrectly written as “Li C, Kaiyu L, Sooranna SR, Bennett PR., Zinging L, Dimitris G, et al. The effect of cAMP on PRE promoter activity in presence or absence of progesterone. In: 57th Annual Meeting of the Society for Gynecologic Investigation, Vol.17. Orlando, FL: Reproductive Sciences (2010). doi: 10.1177/193371912010173s067”. It should be “Rakers F, Schleußner E, Muth I, Hoyer D, Rupprecht S, Schiecke K, et al. Impact of antenatal glucocorticoid exposure on activity of the stress system, cognition and behavior in 8–9-year-old children: a clinical cohort study. (in preparation).”

The publisher apologizes for this mistake. The original article has been updated.

Keywords: multiple sclerosis, glucocorticoids, methylprednisolone, cognition, pituitary-adrenal axis

Citation: Frontiers Production Office (2023) Erratum: Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children). Front. Neurol. 14:1213956. doi: 10.3389/fneur.2023.1213956

Received: 28 April 2023; Accepted: 28 April 2023;
Published: 15 May 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.